Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C-J Busch

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|July 21, 2009
Selective inhibition of guanylate cyclase prevents impairment of hypoxic pulmonary vasoconstriction in endotoxemic miceF Spohr, C J Busch, P Teschendorf, et al.
Cancer Treatment Reviews|February 18, 2015
The current role of systemic chemotherapy in the primary treatment of head and neck cancerC-J Busch, S Tribius, P Schafhausen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 3, 2017
Current studies of immunotherapy in head and neck cancerV Dogan, T Rieckmann, A Münscher, et al.
HNO|September 15, 2016
[Immunotherapy for HNSCC : Quo vadis?]J Döscher, C-J Busch, P J Schuler, et al.
HNO|September 9, 2016
[Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting]C-J Busch, S Laban, R Knecht, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 24, 2004
Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytesC J Busch, G A Wanner, M D Menger, et al.
HNO|October 10, 2014
[Therapy of recurrent or metastatic head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014]N Zeller, C-J Busch, P Schafhausen, et al.
HNO|November 14, 2013
[The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013]A Münscher, C-J Busch, P Schafhausen, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 13, 2013
New treatment strategies for HPV-positive head and neck cancerB Kofler, S Laban, C J Busch, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 28, 2015
Timing of neck dissection in patients undergoing transoral robotic surgery for head and neck cancerN Möckelmann, C-J Busch, A Münscher, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|July 21, 2009
Selective inhibition of guanylate cyclase prevents impairment of hypoxic pulmonary vasoconstriction in endotoxemic miceF Spohr, C J Busch, P Teschendorf, et al.
Cancer Treatment Reviews|February 18, 2015
The current role of systemic chemotherapy in the primary treatment of head and neck cancerC-J Busch, S Tribius, P Schafhausen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 3, 2017
Current studies of immunotherapy in head and neck cancerV Dogan, T Rieckmann, A Münscher, et al.
HNO|September 15, 2016
[Immunotherapy for HNSCC : Quo vadis?]J Döscher, C-J Busch, P J Schuler, et al.
HNO|September 9, 2016
[Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting]C-J Busch, S Laban, R Knecht, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 24, 2004
Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytesC J Busch, G A Wanner, M D Menger, et al.
HNO|October 10, 2014
[Therapy of recurrent or metastatic head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014]N Zeller, C-J Busch, P Schafhausen, et al.
HNO|November 14, 2013
[The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013]A Münscher, C-J Busch, P Schafhausen, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 13, 2013
New treatment strategies for HPV-positive head and neck cancerB Kofler, S Laban, C J Busch, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 28, 2015
Timing of neck dissection in patients undergoing transoral robotic surgery for head and neck cancerN Möckelmann, C-J Busch, A Münscher, et al.
Pageof 5